The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.In this report, we mainly study the drugs and eye drops for dry eye.
The global Dry Eye Syndrome market was valued at US$ 5385 million in 2023 and is anticipated to reach US$ 7355.1 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%.
North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent.
In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Syndrome.
Report Scope
The Dry Eye Syndrome market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Eye Syndrome manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.
Market Segmentation
By Company
- Allergan
- Alcon
- Novartis
- Santen Pharma
- Johnson & Johnson
- Bausch & Lomb
- Thea pharmaceuticals
- URSAPHARM
- SIMILASAN
- Akorn
- United Laboratories
- Sun Pharmaceutical
- Jianfeng Group
Segment by Type
- Artificial Tears
- Anti-inflammatory Drugs
- Others
Segment by Distribution Channel
- Hospital
- Retail Pharmacy
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dry Eye Syndrome manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dry Eye Syndrome in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Dry Eye Syndrome Market Overview
1.1 Product Overview and Scope of Dry Eye Syndrome
1.2 Dry Eye Syndrome Segment by Type
1.2.1 Global Dry Eye Syndrome Market Value Comparison by Type (2024-2030)
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Others
1.3 Dry Eye Syndrome Segment by Distribution Channel
1.3.1 Global Dry Eye Syndrome Market Value by Distribution Channel: (2024-2030)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Dry Eye Syndrome Market Size Estimates and Forecasts
1.4.1 Global Dry Eye Syndrome Revenue 2019-2030
1.4.2 Global Dry Eye Syndrome Sales 2019-2030
1.4.3 Global Dry Eye Syndrome Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dry Eye Syndrome Market Competition by Manufacturers
2.1 Global Dry Eye Syndrome Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dry Eye Syndrome Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dry Eye Syndrome Average Price by Manufacturers (2019-2024)
2.4 Global Dry Eye Syndrome Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dry Eye Syndrome, Product Type & Application
2.7 Dry Eye Syndrome Market Competitive Situation and Trends
2.7.1 Dry Eye Syndrome Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dry Eye Syndrome Players Market Share by Revenue
2.7.3 Global Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dry Eye Syndrome Retrospective Market Scenario by Region
3.1 Global Dry Eye Syndrome Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dry Eye Syndrome Global Dry Eye Syndrome Sales by Region: 2019-2030
3.2.1 Global Dry Eye Syndrome Sales by Region: 2019-2024
3.2.2 Global Dry Eye Syndrome Sales by Region: 2025-2030
3.3 Global Dry Eye Syndrome Global Dry Eye Syndrome Revenue by Region: 2019-2030
3.3.1 Global Dry Eye Syndrome Revenue by Region: 2019-2024
3.3.2 Global Dry Eye Syndrome Revenue by Region: 2025-2030
3.4 North America Dry Eye Syndrome Market Facts & Figures by Country
3.4.1 North America Dry Eye Syndrome Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dry Eye Syndrome Sales by Country (2019-2030)
3.4.3 North America Dry Eye Syndrome Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dry Eye Syndrome Market Facts & Figures by Country
3.5.1 Europe Dry Eye Syndrome Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dry Eye Syndrome Sales by Country (2019-2030)
3.5.3 Europe Dry Eye Syndrome Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Eye Syndrome Market Facts & Figures by Country
3.6.1 Asia Pacific Dry Eye Syndrome Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dry Eye Syndrome Sales by Country (2019-2030)
3.6.3 Asia Pacific Dry Eye Syndrome Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dry Eye Syndrome Market Facts & Figures by Country
3.7.1 Latin America Dry Eye Syndrome Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dry Eye Syndrome Sales by Country (2019-2030)
3.7.3 Latin America Dry Eye Syndrome Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Eye Syndrome Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Eye Syndrome Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dry Eye Syndrome Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dry Eye Syndrome Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dry Eye Syndrome Sales by Type (2019-2030)
4.1.1 Global Dry Eye Syndrome Sales by Type (2019-2024)
4.1.2 Global Dry Eye Syndrome Sales by Type (2025-2030)
4.1.3 Global Dry Eye Syndrome Sales Market Share by Type (2019-2030)
4.2 Global Dry Eye Syndrome Revenue by Type (2019-2030)
4.2.1 Global Dry Eye Syndrome Revenue by Type (2019-2024)
4.2.2 Global Dry Eye Syndrome Revenue by Type (2025-2030)
4.2.3 Global Dry Eye Syndrome Revenue Market Share by Type (2019-2030)
4.3 Global Dry Eye Syndrome Price by Type (2019-2030)
5 Segment by Distribution Channel
5.1 Global Dry Eye Syndrome Sales by Distribution Channel (2019-2030)
5.1.1 Global Dry Eye Syndrome Sales by Distribution Channel (2019-2024)
5.1.2 Global Dry Eye Syndrome Sales by Distribution Channel (2025-2030)
5.1.3 Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2019-2030)
5.2 Global Dry Eye Syndrome Revenue by Distribution Channel (2019-2030)
5.2.1 Global Dry Eye Syndrome Revenue by Distribution Channel (2019-2024)
5.2.2 Global Dry Eye Syndrome Revenue by Distribution Channel (2025-2030)
5.2.3 Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2019-2030)
5.3 Global Dry Eye Syndrome Price by Distribution Channel (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Dry Eye Syndrome Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Alcon
6.2.1 Alcon Corporation Information
6.2.2 Alcon Description and Business Overview
6.2.3 Alcon Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alcon Dry Eye Syndrome Product Portfolio
6.2.5 Alcon Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Dry Eye Syndrome Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Santen Pharma
6.4.1 Santen Pharma Corporation Information
6.4.2 Santen Pharma Description and Business Overview
6.4.3 Santen Pharma Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Santen Pharma Dry Eye Syndrome Product Portfolio
6.4.5 Santen Pharma Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Dry Eye Syndrome Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Bausch & Lomb
6.6.1 Bausch & Lomb Corporation Information
6.6.2 Bausch & Lomb Description and Business Overview
6.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bausch & Lomb Dry Eye Syndrome Product Portfolio
6.6.5 Bausch & Lomb Recent Developments/Updates
6.7 Thea pharmaceuticals
6.6.1 Thea pharmaceuticals Corporation Information
6.6.2 Thea pharmaceuticals Description and Business Overview
6.6.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thea pharmaceuticals Dry Eye Syndrome Product Portfolio
6.7.5 Thea pharmaceuticals Recent Developments/Updates
6.8 URSAPHARM
6.8.1 URSAPHARM Corporation Information
6.8.2 URSAPHARM Description and Business Overview
6.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.8.4 URSAPHARM Dry Eye Syndrome Product Portfolio
6.8.5 URSAPHARM Recent Developments/Updates
6.9 SIMILASAN
6.9.1 SIMILASAN Corporation Information
6.9.2 SIMILASAN Description and Business Overview
6.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SIMILASAN Dry Eye Syndrome Product Portfolio
6.9.5 SIMILASAN Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Akorn Dry Eye Syndrome Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 United Laboratories
6.11.1 United Laboratories Corporation Information
6.11.2 United Laboratories Dry Eye Syndrome Description and Business Overview
6.11.3 United Laboratories Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.11.4 United Laboratories Dry Eye Syndrome Product Portfolio
6.11.5 United Laboratories Recent Developments/Updates
6.12 Sun Pharmaceutical
6.12.1 Sun Pharmaceutical Corporation Information
6.12.2 Sun Pharmaceutical Dry Eye Syndrome Description and Business Overview
6.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sun Pharmaceutical Dry Eye Syndrome Product Portfolio
6.12.5 Sun Pharmaceutical Recent Developments/Updates
6.13 Jianfeng Group
6.13.1 Jianfeng Group Corporation Information
6.13.2 Jianfeng Group Dry Eye Syndrome Description and Business Overview
6.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jianfeng Group Dry Eye Syndrome Product Portfolio
6.13.5 Jianfeng Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Eye Syndrome Industry Chain Analysis
7.2 Dry Eye Syndrome Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Eye Syndrome Production Mode & Process
7.4 Dry Eye Syndrome Sales and Marketing
7.4.1 Dry Eye Syndrome Sales Channels
7.4.2 Dry Eye Syndrome Distributors
7.5 Dry Eye Syndrome Customers
8 Dry Eye Syndrome Market Dynamics
8.1 Dry Eye Syndrome Industry Trends
8.2 Dry Eye Syndrome Market Drivers
8.3 Dry Eye Syndrome Market Challenges
8.4 Dry Eye Syndrome Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
